Pacific Biosciences Of California Inc Asset Turnover Ratio (PACB), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Pacific Biosciences Of California Inc   (NASDAQ: PACB)
 

Pacific Biosciences Of California Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Pacific Biosciences Of California Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.2 in the second quarter (Jun 30 2026)

Within sector 17 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 2535 to 2878.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PACB Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change -8.92 % -9 % -37 % -44.07 % -44.57 %
Y / Y Revenue Change -1.71 % 0.58 % 13.75 % -2.83 % 10.42 %
Asset Turnover Ratio (TTM) 0.2 0.2 0.2 0.17 0.14
PACB's Total Ranking # 2878 # 2535 # 1763 # 2104 # 2252
Seq. Asset Change -4.1 % -0.21 % -2.18 % -2.7 % -4.18 %
Seq. Revenue Change 5.88 % -19.15 % 20.22 % -4.49 % 8.34 %



Asset Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 18
Healthcare Sector # 426
Overall Market # 2878

Asset Turnover Ratio Statistics
High Average Low
0.85 0.33 0.07
(Dec 31 2015)   (Dec 31 2022)




PACB Company Profile • Back to PACB Efficiency Comparisons • Compare PACB Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Capsovision Inc   0.58 $ 12.804  Millions$ 22.085  Millions
Merit Medical Systems Inc  0.58 $ 1,579.403  Millions$ 2,724.956  Millions
Enovis Corp  0.58 $ 2,294.938  Millions$ 3,966.621  Millions
Stereotaxis Inc   0.58 $ 29.892  Millions$ 51.863  Millions
Adaptive Biotechnologies Corporation  0.57 $ 308.081  Millions$ 537.492  Millions
Supernus Pharmaceuticals inc   0.57 $ 830.438  Millions$ 1,450.309  Millions
Baxter International Inc   0.57 $ 11,555.000  Millions$ 20,189.750  Millions
Livanova Plc  0.57 $ 1,470.112  Millions$ 2,580.212  Millions
Mannkind Corporation  0.57 $ 393.630  Millions$ 690.882  Millions
Bruker Corporation  0.56 $ 3,498.900  Millions$ 6,214.975  Millions
Agilent Technologies inc   0.56 $ 7,372.000  Millions$ 13,121.500  Millions
Haemonetics Corporation  0.56 $ 1,351.722  Millions$ 2,413.607  Millions
Vsee Health Inc   0.56 $ 10.759  Millions$ 19.218  Millions
Intuitive Surgical Inc   0.56 $ 11,296.300  Millions$ 20,199.525  Millions
Vireo Growth Inc.  0.55 $ 511.706  Millions$ 924.643  Millions
Ceribell Inc   0.55 $ 101.804  Millions$ 184.939  Millions
Cormedix Inc   0.55 $ 451.943  Millions$ 824.173  Millions
Stryker Corp  0.55 $ 25,837.000  Millions$ 47,280.500  Millions
Gilead Sciences Inc   0.55 $ 30,457.000  Millions$ 55,799.000  Millions
Viskase Holdings inc   0.55 $ 177.054  Millions$ 324.798  Millions
Bristol myers Squibb Company  0.54 $ 49,186.000  Millions$ 90,259.250  Millions
Transmedics Group Inc   0.54 $ 668.468  Millions$ 1,228.405  Millions
American Shared Hospital Services  0.54 $ 30.210  Millions$ 55.582  Millions
Ultragenyx Pharmaceutical Inc   0.54 $ 717.212  Millions$ 1,320.611  Millions
Integer Holdings Corporation  0.54 $ 1,842.621  Millions$ 3,410.801  Millions
Glaukos Corp  0.54 $ 500.031  Millions$ 926.678  Millions
Icu Medical Inc  0.54 $ 2,159.998  Millions$ 4,034.612  Millions
Charles River Laboratories International inc   0.53 $ 3,998.987  Millions$ 7,477.922  Millions
Foxo Technologies Inc   0.53 $ 24.846  Millions$ 47.087  Millions
Rhythm Pharmaceuticals Inc   0.51 $ 239.918  Millions$ 466.663  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.